Chemomab Therapeutics News

Chemomab Therapeutics | EFFECT: Others

Dec 11, 2024 07:16 ET

Chemomab Therapeutics | 424B5: Prospectus

Nov 15, 2024 16:10 ET

Chemomab Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 12, 2024 16:59 ET

Chemomab Therapeutics | 424B3: Prospectus

Sep 9, 2024 06:20 ET

Chemomab Therapeutics | EFFECT: Others

Sep 9, 2024 06:06 ET

Chemomab Therapeutics | EFFECT: Others

Nov 6, 2023 00:15 ET

Chemomab Therapeutics | 424B5: Prospectus

Apr 25, 2022 16:19 ET

Chemomab Therapeutics | EFFECT: Others

May 18, 2021 00:15 ET

Chemomab Therapeutics | 424B3: Prospectus

Apr 29, 2021 06:10 ET

Chemomab Therapeutics | EFFECT: Others

Apr 29, 2021 00:15 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 9, 2021 18:32 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 9, 2021 13:00 ET

Chemomab Therapeutics | 424B3: Prospectus

Feb 12, 2021 12:05 ET

Chemomab Therapeutics | EFFECT: Others

Feb 11, 2021 00:15 ET

Chemomab Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Feb 10, 2021 13:19 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 8, 2021 14:15 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 2, 2021 09:22 ET

Chemomab Therapeutics | S-4: Registration of securities issued in business combination transactions

Jan 13, 2021 09:30 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 11, 2021 10:50 ET

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 5, 2021 09:36 ET